Lombardi Cancer Center-Georgetown University — Washington D.C., District of Columbia

Lombardi Cancer Center-Georgetown University is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 52/100 (POOR). This profile has not yet been claimed by the site owner.

Lombardi Cancer Center-Georgetown University has participated in 2 clinical trials.

Therapeutic areas: Diffuse Cutaneous Systemic Sclerosis, Follicular Lymphoma, Chronic Lymphocytic Leukemia.

Sponsors: CSL Behring, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 52/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Cancer Center-Georgetown University?

Lombardi Cancer Center-Georgetown University has a Crixeo Trust Score of 52/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Cancer Center-Georgetown University conducted?

Lombardi Cancer Center-Georgetown University has 2 clinical trials on record. Their work covers Diffuse Cutaneous Systemic Sclerosis, Follicular Lymphoma, Chronic Lymphocytic Leukemia.

Is Lombardi Cancer Center-Georgetown University accredited by Crixeo Health?

Lombardi Cancer Center-Georgetown University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lombardi Cancer Center-Georgetown University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.